Quantifying age-associated differences in the durability of Shingrix-induced immunity using mathematical modelling

Understanding the durability of vaccine-induced immunity is critical for evaluating long-term protection and vaccine scheduling, particularly in aging populations where immunosenescence may alter immune response dynamics. In this study, we used a novel mathematical modelling pipeline to quantify age-related differences in the contraction and persistence phases of gE-specific CD4+ T cell and anti-gE antibody responses following Shingrix vaccination. Specifically, we developed a semi-mechanistic model to expand virtual populations that captured inter-individual variability in peak concentrations and waning dynamics. To compare immune responses across age groups, we introduced a time varying, age-related immune advantage metric that measures the probability of a randomly selected younger individual exhibiting a stronger immune response than one from an older group. By evaluating this metric across multiple simulated virtual populations, our results demonstrate clear and sustained age-related differences in both gE-specific CD4+ T cells and anti-gE antibody responses, with younger age groups consistently exhibiting higher responses. Given these age-related differences, we used our model to explore alternative vaccine schedules in older age groups. These exploratory simulations suggest that booster doses administered between 6 and 12 months following the second dose may mitigate age-related differences in antibody dynamics. This work highlights the use of mechanistic mathematical modelling to disentangle age-associated differences in vaccine outcomes and lead to designing of plausible improvement in age-specific vaccine schedules.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.10.26367539
Primary Topic
Herpesvirus Infections and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Quantifying age-associated differences in the durability of Shingrix-induced immunity using mathematical modelling

Morgan Craig, David A. G. Skibinski, Guy De La Rosa, Soren M. Gantt et al.
medRxiv
Herpesvirus Infections and Treatments
preprint

Quantifying age-associated differences in the durability of Shingrix-induced immunity using mathematical modelling

Morgan Craig, David A. G. Skibinski, Guy De La Rosa, Soren M. Gantt, Lisa Shelton, Terry Easlick, Haijing Qin
preprint en

Abstract

Understanding the durability of vaccine-induced immunity is critical for evaluating long-term protection and vaccine scheduling, particularly in aging populations where immunosenescence may alter immune response dynamics. In this study, we used a novel mathematical modelling pipeline to quantify age-related differences in the contraction and persistence phases of gE-specific CD4+ T cell and anti-gE antibody responses following Shingrix vaccination. Specifically, we developed a semi-mechanistic model to expand virtual populations that captured inter-individual variability in peak concentrations and waning dynamics. To compare immune responses across age groups, we introduced a time varying, age-related immune advantage metric that measures the probability of a randomly selected younger individual exhibiting a stronger immune response than one from an older group. By evaluating this metric across multiple simulated virtual populations, our results demonstrate clear and sustained age-related differences in both gE-specific CD4+ T cells and anti-gE antibody responses, with younger age groups consistently exhibiting higher responses. Given these age-related differences, we used our model to explore alternative vaccine schedules in older age groups. These exploratory simulations suggest that booster doses administered between 6 and 12 months following the second dose may mitigate age-related differences in antibody dynamics. This work highlights the use of mechanistic mathematical modelling to disentangle age-associated differences in vaccine outcomes and lead to designing of plausible improvement in age-specific vaccine schedules.

medRxiv
Centre Hospitalier Universitaire Sainte-Justine (CA), Institut de Recherche Vaccinale (FR), CHU Sainte-Justine Research Center (CA), Université de Montréal (CA)
Good health and well-being
Herpesvirus Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon